Search results
Showing results for
Single-cell ancestry vaccine research funded by the Chan Zuckerberg Initiative
17 November 2021
The Chan Zuckerberg Initiative (CZI) has provided $2 million in funding to investigate how our ancestry and diversity influence the way that vaccines work in our cells.
Large genetic study suggests shared biological processes cause irritable bowel syndrome and anxiety
5 November 2021
An international study of more than 50,000 people with irritable bowel syndrome (IBS) has revealed that IBS symptoms may be caused by the same biological processes as conditions such as anxiety. The research highlights the close relationship between brain and gut health and paves the way for development of new treatments.
New therapeutic targets identified to treat inflammatory bowel disease
22 October 2021
Millions of patients with ulcerative colitis or Crohn’s disease, collectively known as inflammatory bowel disease (IBD), are given fresh hope as a new study shows why some of them do not respond to current treatments.
Oxford-Bristol Myers Squibb Fellowships awarded to NDORMS researchers
18 October 2021
Researchers from the Kennedy Institute of Rheumatology have been awarded fellowships as part of the Oxford-Bristol Myers Squibb Fellowship Programme. Among six researchers from across NDORMS, the programme provides them with an opportunity to gain exposure to the field of commercial drug discovery and development.
Labelling proteins through the diet gives new insights into how collagen-rich tissues change as we age
15 October 2021
A new study, published in eLife, uses advanced tissue analysis technology to show how the incorporation of new proteins changes in bone and cartilage with age.
Novo Nordisk Postdoctoral Research Fellowship awarded to Inhye Park
6 October 2021
Inhye Park has been awarded a Novo Nordisk Postdoctoral Research Fellowship to research the biology of resident vascular macrophages in atherosclerosis.
The Kennedy Institute Student Symposium returns for its 5th year
30 September 2021
A two-day student symposium returned to the Kennedy Institute bringing together students and peers from across the department to discuss their latest research.
Researchers from the Kennedy Institute awarded MRC funding
29 September 2021
Tonia Vincent, Jelena Bezbradica and Alex Clarke have been awarded funding grants by the Medical Research Council (MRC) for different projects.
New Associate Professors announced at NDORMS
17 September 2021
The Medical Sciences Division has awarded the title of Associate Professor to five senior researchers at NDORMS
The Kennedy Institute completes its roof extension
17 August 2021
Building work at the Kennedy Institute of Rheumatology has finished, providing a new third floor that houses additional meeting and collaboration space for data science and offices for the management of clinical trials.
Unlocking the secrets of the microbiome
16 August 2021
Jethro Johnson, Deputy Director of the Oxford Centre for Microbiome Studies explains how the centre is building a research community to understand the microbiome and harness its power to promote health and prevent disease.
Into the future: watching biology unfold
6 August 2021
As part of the University of Oxford’s mission to provide its researchers with the newest state-of-the-art optical imaging equipment and as part of a strategic partnership with the Kennedy Institute of Rheumatology (KIR), the Institute of Developmental and Regenerative Medicine (IDRM), and Carl Zeiss AG (ZEISS), ZEISS has installed a ZEISS Lattice Lightsheet 7 microscope at the KIR.
Neutrophil molecular wiring revealed: transcriptional blueprint of short-lived cells
26 July 2021
Researchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.
Researchers show the role of cilia in cartilage health
15 July 2021
New research shows that disrupting primary cilia in juvenile, adolescent and early adulthood in cartilage stops it maturing correctly, making it more prone to thinning and the potential for osteoarthritis (OA) in later life.
Exploring the link between joint injury and osteoarthritis
25 June 2021
A new study published in The Lancet Rheumatology shows potential ways to predict how likely someone is to develop osteoarthritis after a knee injury.
Doctor Ghada Alsaleh awarded a Versus Arthritis Career Development Fellowship
21 June 2021
Postdoctoral Researcher Ghada Alsaleh has been awarded a research grant by Versus Arthritis which she will use to develop a new therapy for osteoarthritis.
New research identifies a role for CD200 in limiting atherosclerosis
10 June 2021
A new study published in Circulation Research by researchers at the Kennedy Institute shows that CD200, an inhibitory immune checkpoint, reduces the development of atherosclerosis.
EPSRC funds research to avert an antibiotics apocalypse
7 June 2021
Researchers at the Kennedy Institute join a collaboration to find new ‘drug-free’ ways of treating illnesses where current treatments have become ineffective due to antibiotic resistance.
Repurposed drug can induce remission of inflammatory arthritis
20 May 2021
Researchers at the Kennedy Institute demonstrate that the drug decitabine can boost regulatory T cell responses.
NDORMS researchers awarded ECTS prizes
18 May 2021
Professor Anjali Kusumbe and Professor Cyrus Cooper have been presented with research awards by the European Calcified Tissue Society (ECTS).